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IN VITRO GENE KNOCKDOWN OF SOX9 AFFECTS CELL SURVIVAL AND
OSTEOGENIC DIFFERENTIATION OF MESENCHYMAL STEM CELLS
S. Stöckl1,2, C. Göttl1,2, J. Grifka1, S. Grässel1,2
1Orthopaedic Surgery, Experimental Orthopaedics, Regensburg, Germany; 2Ctr.
for Med. Biotechnology, Regensburg, Germany
Purpose: The transcription factor Sox9 plays an important role in the
regulation of skeletal growth and cartilage formation. It is absent in hyper-
trophic chondrocytes, where a misexpression in vivo causes lack of bone
marrow, inhibition of cartilage resorption and failure of vascular invasion.
Moreover, there is evidence that Sox9 is related to more biological processes
then only to osteo-chondrogenesis. The aim of our study is to determine
the role of Sox9 in undifferentiated rat mesenchymal stem cells (rMSC) for
cell survival and its impact on osteogenic differentiation capacity.
Methods: rMSC were isolated from the femoral bone marrow of ﬁve
week old CD-rats and cultured in monolayer for one passage. Cells were
seeded at low density and transduced with a retroviral vector containing
a Sox9-speciﬁc shRNA. After antibiotic selection, the Sox9 knockdown
was determined with quantitative real-time PCR (qRT-PCR) and western
blot. Downstream effects of the reduced Sox9 level in undifferentiated
rMSC were investigated by qRT-PCR. Proliferation was quantiﬁed with a
BrdU-ELISA based assay and the apoptotic activity with a caspase 3/7 assay.
For transduced cells, subjected to osteogenic differentiation for up to 21
days, osteogenic marker gene expression was analyzed via qRT-PCR.
Results: A reproducible Sox9 knockdown >75% was generated on the
mRNA and protein level. Downstream effects were a signiﬁcant down
regulation of Col1a1, Sox6, Sox5 Vegfa, Integrin alpha 11, Mmp13, Runx2
and Bcl-2 gene expression whereas Osteocalcin was strongly up regulated.
The BrdU assay indicated ∼ 20% reduction of proliferation and the caspase
3/7 assay displayed a ∼ 12% increase in apoptotic activity after Sox9 silenc-
ing. Preliminary results from osteogenically differentiated rMSC showed
an increased up regulation of Osteocalcin, Runx2, Vegfa and Mmp13 gene
expression in cells with diminished Sox9 copies vs. control cells during and
after termination of osteogenesis.
Conclusion: Based on these knockdown studies we conclude a positive
effect of Sox9 on proliferation and on cell viability. We moreover postulate
a possible interaction between Bcl-2 and Sox9 early in undifferentiated
MSC prior to onset of chondrogenic/osteogenic differentiation, emphasizing
an important role of Sox9 for viability and survival of multipotent precursor
cells. Furthermore, our results may hint to an acceleration of osteogenic
differentiation due to inhibition Sox9.
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CHONDROGENIC POTENTIALITY OF HYPOXIA ON HUMAN BONE MARROW
MESENCHYMAL STEM CELLS IN THREE DIMENSIONAL CULTURE
C. Henrionnet, G. Liang, L. Galois, D. Mainard, D. Bensoussan, J. Magdalou,
P. Gillet, A. Pinzano
UMR 7561 CNRS-Nancy Univ., Vandoeuvre les Nancy, France
Purpose: Human bone marrow mesenchymal stem cells (MSCs) are proved
to be a good candidate cell source for treating cartilage defects. This is
due to their ability to undergo chondrogenic differentiation after extensive
expansion in vitro in three-dimensional (3-D) systems. Differentiation of
MSCs into chondrocytes in vitro has been studied by means of exposure to
exogenous growth factors, coculture with cartilage, and overexpression of
speciﬁc genes to promote chondrogenic gene expression. In vivo, cartilage
resides in a low oxygen microenvironnement and is exposed to hypoxic
conditions (1-10% oxygen). Most in vitro tissue engineering strategies are
performed within 20% oxygen environment, but it is becoming clear that
Abstract 521 – Figure 1. For each gene in each culture condition, the reference value 1 is given to the lower expression level.
changes in ambient oxygen levels exert a profound inﬂuence in chon-
drogenesis. Oxygen tension seems to be an important regulatory factor
in chondrocytes culture that inﬂuences the expression of chondrogenic
phenotypic genes and cartilage speciﬁc matrix formation. The aim of our
study was to evaluate the inﬂuence of hypoxic conditions on chondrogenic
differentiation of human mesenchymal stem cells in 3D culture (alginate
beads supplemented with hyaluronic acid).
Methods: Mesenchymal stem cells issued from human bone marrow were
expanded in monolayer under hypoxia (5% O2) or normoxia (21% O2)
culture condition. After this monolayer expansion, mesenchymal stem cells
were seeded in alginate bead (3D culture) enriched with hyaluronic acid
and cultured in normoxia (21% O2) or in hypoxia (5% O2) with or without
growth factor supplementation (TGFβ1, BMP-2). At D28, expression of
cartilage interest genes and quality of synthesized extracellular matrix
were analyzed respectively by using RT-PCRq, histology and immunohisto-
chemistry (coll 1, coll 2).
Results: A strong increase of type 2 collagen expression was observed at
D28 with growth factors. This increase was more important with BMP-2
combinated with TGF-β1 compared to TGF-β1 alone. BMP-2 alone was
ineﬃcient to increase collagen 2 basal expression observed with FBS or
ITS. Interestingly, a signiﬁcant increase of these inductions in hypoxia
culture condition was observed. Hypoxia 3D culture condition enhanced
signiﬁcantly sox 9 and aggrecan expressions. COMP and versican expres-
sions were not signiﬁcantly inﬂuenced by hypoxia. Osteocalcin and alkaline
phosphatase, exerting a low basal gene expressions, were not modiﬁed
by hypoxia. Moreover, monolayer culture (expansion phase) under hy-
poxia increased the induction of Coll 2 chondrocytic gene, particularly
type 2B. Histologically, hypoxia induces an abundant newly synthetized
extracellular matrix, rich in proteoglycan and collagen, mainly type 2.
Conclusions: Chondrogenic differentiation of mesenchymal stem cells in
combination with growth factors in alginate beads is signiﬁcantly favored
by their exposition to hypoxia condition in monolayer and in 3D culture
conditions. Moreover, the preconditioning of monolayer culture under
hypoxia potentializes the induction of type 2 collagen in 3D culture.
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SEARCHING FOR A WELL-DEFINED AND EFFICIENT METHOD FOR IN
VITRO DIRECTING STEM CELL DIFFERENTIATION INTO THE
CHONDROGENIC LINEAGE
C. Cicione1 , S. Diaz-Prado1,2, E. Muiños1, I. Fuentes-Boquete1,2 , F.J. De
Toro1,2, F.J. Blanco1
1Osteoarticular and Aging Res. Lab. CIBER-BBN. Rheumatology Div.
INIBIC-Complejo Hosp. Univ. A Coruña, A Coruña, Spain; 2INIBIC-Univ. of A
Coruña, A Coruña, Spain
Purpose: The use of autologous or allogenic stem cells is suggested as an
alternative therapeutic approach for treatment of cartilage defects. The aim
of this study was to develop a well-deﬁned and eﬃcient method for in vitro
directing bone marrow mesenchymal stem cells (BM-MSCs) differentiation
into the chondrogenic lineage both in normoxic and in hypoxic conditions.
Methods: At the third passage, BM-MSCs (n= 3) were characterized by ﬂow
cytometry and differentiated for 14th days towards chondrogenic lineage
by the use of three different growth factors: A (Control: DMEM+15% KO
serum), B (TGFβ-3 1ng/ml), C (TGFβ-3 10ng/ml), D (BMP-2 10ng/ml), E
(BMP-7 10ng/ml) and F (TGFβ-3 1ng/ml+ BMP-2 10ng/ml+ BMP-7 10ng/ml).
Chondrogenic differentiation of BM-MSCs was conﬁrmed by the use of
histochemical, immunohistochemical and qPCR techniques.
Results: BM-MSCs displayed similar surface antigen expressions. As shown
in the graphic, gene expression levels of Sox9, Agg and Col1A1 was
measured in the different chondrogenic culture mediums (Fig. 1). The gene
expression of Col2A1 was detectable only in F and C medium.
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Conclusions: In our experimental conditions, the capability to induce
chondrogenic differentiation depends on the culture conditions used. The
transcription factor that actuates better in normoxic condition differs from
the one that displays a better action in a hypoxic atmosphere.
Acknowledgements: C Cicione: Foundation CHU A Coruña, Spain. S Diaz:
"Isidro Parga Pondal"-Xunta Galicia, Spain. E Muíños: Fellowship Rheum.
Spanish Foundation.
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GENE EXPRESSION CHANGES ASSOCIATEDWITH CHONDROGENIC
DIFFERENTIATION OF HUMANMSCS
J.F. Welter, L.A. Solchaga, K.J. Penick, P. Leahy, A.I. Caplan, V.M. Goldberg
Case Western Reserve Univ., Cleveland, OH
Purpose: Human mesenchymal stem cells (hMSCs) are useful for cartilage
tissue engineering as they can differentiate into chondrocyte-like cells
under conditions including high cell density and a deﬁned medium. Carti-
lage markers become detectable at the RNA and protein levels within the
ﬁrst week of differentiation. The phenotypic changes are the result of a
reprogramming of the gene expression and physiology of MSCs. To support
our studies of chondrogenic MSC differentiation, we used gene expression
microarrays to understand the sequence and extent of these changes.
Methods: Five hMSC preparations were derived from bone marrow aspi-
rates obtained under an IRB-approved protocol. The cells were expanded
through the end of ﬁrst passage in DMEM with serum and 10 ng/ml
FGF-2, then moved to aggregate culture in chondrogenic medium to
induce differentiation. Total RNA was extracted from 20 aggregates per
prep at days 0, 1, 3, 5, and 7; 5-8 μg of RNA were reverse-transcribed.
The three best cDNA preps were analyzed using Affymetrix U133A 2.0
microarrays. Spiked bacterial IVT were used as hybridization controls. Raw
data generated using GCOS software were scaled to 500 and imported into
Agilent GeneSpring 6.4. A short list of interesting genes was generated
by binary comparisons at each time point using MAS5.0 algorithms in
GCOS. Transcripts consistently called as increased or decreased in all three
preparations with an average absolute fold change ≥ 2.0 were included.
For genes referenced by multiple probesets, consistency checks were per-
formed, and we used the median value of the probesets. Filtered data were
then analyzed using GeneSpring, Ariadne Genomics Pathway Studio and
Partek Genomics Suite. Cluster analysis and principal component analysis
were performed on the ﬁltered data. A 3 × 3 array of self-organizing maps
(SOM) was created, and regulation pattern detection was performed; ﬁnally
assignment to speciﬁc cellular pathways attempted. We also mined the
database for chondrogenesis-related genes known to be modulated during
MSC differentiation from our experiments or from published reports.
Results: All arrays passed internal quality control. After ﬁltering the data,
we found a high-value population of 3,285 differentially expressed genes.
Cluster and SOM analysis revealed that most of the changes occurred be-
tween days 0 and 1 (1,723) or 2, with fewer changes occurring later. Small
subsets spiked or plummeted transiently on day one, even smaller subsets
showed steady in- or decreases over the study period. Pathway assignment
performed on the SOM groups suggests that genes regulating transcription,
cell-cycle, cell adhesion, and differentiation are highly regulated (both up
and down) beginning at the earliest time points.
Conclusions: We have a stringent database of gene expression changes
during early chondrogenic differentiation of hMSCs. Pattern analyses in-
dicate that most changes occur within the ﬁrst day and are permanent;
this suggests genes turned on or off during differentiation that are, thus,
MSC- or chondrocyte-speciﬁc. A much smaller set was transient, suggesting
involvement in gene expression regulation and lineage commitment. The
number of regulated genes affecting transcription, cell-cycle, cell adhesion,
and differentiation reﬂects the signiﬁcant reprogramming of the cells in the
transition from proliferation to differentiation. The database will be a use-
ful tool for interpreting molecular changes associated with chondrogenic
differentiation of MSCs.
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EFFECT OF FIBRONECTIN SPLICING ON CELL PROLIFERATION AND
CHONDROCYTE-SPECIFIC GENE EXPRESSION IN A MESENCHYMAL STEM
CELL SYSTEM
S.A. Jami, N.B. Sepulveda, J.H. Peters
UC Davis, Sacramento, CA
Purpose: During embryonic development, expression of ﬁbronectins (FNs)
bearing the alternatively spliced EIIIA and V segments is prevalent in
prechondrogenic mesenchymal cell condensations. However, expression of
these FNs becomes restricted near the time of chondrogenesis, suggesting
that they may not be compatible with processes by which mesenchymal
stem cells (MSCs) differentiate to chondrocytes.
Methods: We tested the effects of the EIIIA and V segments, expressed as
glutathione S-transferase (GST) fusion proteins, adsorbed to plastic or in
solution, on proliferation and gene expression in rat RCJ 3.1 multipotential
mesenchymal cells, an MSC model cell line, using 3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and real-time PCR. A
GST fusion protein containing the 10th type III repeat of FN (III-10) and
poly-L-lysine (PLL) were also tested.
Results: In 15% fetal bovine serum (FBS), cells grown in monolayer for 7
days (d) on surfaces coated with EIIIA, V, III-10, or PLL appeared conﬂuent,
and attained similar MTT scores, with OD570-630 values (average±S.D.)
of 1.3±0.8, 1.4±0.8, 1.3±0.7, and 1.5±1.0, respectively (ns, N=3). Under
serum-free conditions, more cells remained adherent to surfaces coated
with III-10 than the other 3 agents after 7 d in HEScGRO (Millipore),
with respective values of 0.2±0.1**, 0.2±0.1**, 0.6±0.2, and 0.4±0.2*. In
KnockoutSR (GIBCO), V and III-10 both promoted greater retention of
adherent cells than EIIIA and PLL, with respective values for the 4 agents
of 0.2±0.0***, 0.6±0.1, 0.7±0.1, and 0.3±0.1**. Aggrecan expression in cells
grown in 15% FBS for 7 d on each of the substrates decreased compared
to cells grown for 1 d on III-10, but not signiﬁcantly so (fold changes of
-1.0±0.7, -0.7±0.6, -2.8±0.1, and -2.6±0.3, respectively) (N=3). In contrast,
aggrecan expression increased in cells grown in pellet culture in the pres-
ence of TGF-b, with a fold change of 2.5±1.0 at 14 d compared to cells at
0 d (ns, N=3). Addition of soluble EIIIA (200 nM) to such cultures triggered
reduced aggrecan expression so that the fold change at 14 d compared to 0
d cells was -7.1±0.1 (18.6-fold reduction compared to untreated cells, ***,
N=3). p>0.05=ns, p<0.05=* o<0.01=***, p<0.001=***
Conclusions: The 10th type III repeat and V segment of FN promote
anchorage-dependent proliferation/survival of RCJ 3.1 MSCs in serum-free
culture. These cells lose aggrecan expression in monolayer culture, and this
is not appreciably affected by apposition to EIIIA, V, or III-10. In contrast,
aggrecan expression increases during pellet culture, and such acquisition of
chondrocyte-speciﬁc gene expression is inhibited by soluble EIIIA, suggest-
ing that this FN segment could potentially constitute a therapeutic target
in efforts to promote chondrocytic differentiation of MSCs, or to reverse
cartilage degeneration in osteoarthritis. Research funded by a VA Merit
grant.
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SEQUENTIALLY PROGRAMMEDMAGNETIC FIELD THERAPY AS AN
EFFECTIVE TREATMENT FOR OSTEOARTHRITIS
V.G. Vasishta Sr.
Former Prof and HOD, Inst. of Aerospace Med., Indian Air Force, Bangalore,
India
Introduction and Purpose: Different modalities of available treatment for
treating osteoarthritis, including newer drugs like NSAIDS, Intra-articular
injections, etc have been tried with very little or no success, leaving
patients with the only surgical option of joint replacement. All of these
except surgery provide only symptomatic relief and do not reverse the
continuous damage done to the cartilage. The newer drugs also come
withmany undesirable side effects. Total knee replacement Surgery (TKR) is
often beyond the ﬁnancial reach of many patients, especially in developing
countries. Even TKR surgery has a severe painful recovery period and a low
patient acceptance. So there has always been a need for a safe treatment
method which would be pain free and also reverse the disease process.
Sequentially Programmed Magnetic Field (SPMF) Therapy utilizes Magnetic
Field Generators (MFG) that can be precisely controlled and focused onto
the affected tissues. The normal physiological remodeling of cartilage oc-
curs due to piezoelectric stimuli which are lost in osteoarthritic patients.
